Wells Fargo & Company Next Cure, Inc. Transaction History

Wells Fargo & Company

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.13 - $2.23 $2,262 - $4,464	2,002 Added 1291.61%	2,157 $4,000
Q4 2023 Feb 09, 2024	BUY	$1.03 - $1.45 $9 - $13	9 Added 6.16%	155 $0
Q3 2023 Nov 13, 2023	BUY	$1.29 - $1.84 $20 - $29	16 Added 12.31%	146 $0
Q2 2023 Aug 15, 2023	BUY	$1.47 - $1.86 $7 - $9	5 Added 4.0%	130 $0
Q1 2023 May 12, 2023	BUY	$1.46 - $1.83 $2 - $3	2 Added 1.63%	125 $0
Q4 2022 Feb 13, 2023	BUY	$1.2 - $3.07 $3 - $9	3 Added 2.5%	123 $0
Q3 2022 Nov 14, 2022	BUY	$2.72 - $5.19 $2 - $5	1 Added 0.84%	120 $0
Q2 2022 Aug 12, 2022	BUY	$3.38 - $5.27 $402 - $627	119 New	119 $1,000
Q1 2022 May 16, 2022	SELL	$4.76 - $6.24 $119 - $156	-25 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.7 - $9.1 $8,949 - $14,287	-1,570 Reduced 98.43%	25 $0
Q3 2021 Nov 15, 2021	SELL	$6.74 - $8.02 $105,905 - $126,018	-15,713 Reduced 90.78%	1,595 $11,000
Q2 2021 Aug 16, 2021	SELL	$7.6 - $10.28 $20,147 - $27,252	-2,651 Reduced 13.28%	17,308 $138,000
Q1 2021 May 13, 2021	SELL	$9.81 - $13.88 $270,716 - $383,032	-27,596 Reduced 58.03%	19,959 $199,000
Q4 2020 Feb 09, 2021	SELL	$9.47 - $12.43 $110,249 - $144,710	-11,642 Reduced 19.67%	47,555 $518,000
Q3 2020 Nov 05, 2020	BUY	$8.15 - $21.17 $24,001 - $62,345	2,945 Added 5.24%	59,197 $521,000
Q2 2020 Aug 13, 2020	BUY	$21.19 - $40.2 $909,093 - $1.72 Million	42,902 Added 321.36%	56,252 $1.21 Million
Q1 2020 May 14, 2020	BUY	$32.32 - $58.37 $431,472 - $779,239	13,350 New	13,350 $495,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.